Rx RadioRx Radio
HomePodcastResourcesShopNewsBusinessTechnologyClinical PracticeDrug Pricing and Access
HomePodcastResourcesShopArticlesCategoriesSearchAbout

Categories

NewsBusinessTechnologyClinical PracticeDrug Pricing and AccessEducationEducation and TrainingGlobal HealthLaw and ComplianceLeadership and DevelopmentManaged CarePatient Care & CounselingPublic HealthResearch and Development
Rx RadioRx Radio

Leading the conversation in pharmacy

Navigation

  • Home
  • Podcast
  • Resources
  • Shop
  • Articles
  • Categories
  • Search

Categories

  • News
  • Business
  • Technology
  • Clinical Practice
  • Drug Pricing and Access
  • Education
  • Education and Training

Company

  • About
  • Privacy Policy
  • Terms of Service

Follow Us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Threads

© 2026 Rx Radio. All rights reserved.

PrivacyTerms
  1. Home
  2. Categories
  3. Drug Pricing and Access

Drug Pricing and Access

Pfizer Withdraws Oxbryta from Market Due to Safety Concerns

Pfizer Withdraws Oxbryta from Market Due to Safety Concerns

CVS Health to Cover Over-the-Counter Birth Control Pill Opill at No Cost

CVS Health to Cover Over-the-Counter Birth Control Pill Opill at No Cost

CVS Health will cover Opill, the first FDA-approved over-the-counter birth control pill, at no cost through CVS Caremark plans, expanding contraceptive access nationwide.